Swiss Practice Recommendations for Chronic Prurigo Including Prurigo Nodularis
International Journal of Dermatology · 2026-12 · 65 (12) · 2497-2508
DOI: 10.1111/ijd.70533 ↗Kurz gefasst
Leitlinie in der Zeitschrift International Journal of Dermatology, online erschienen am 18.06.2026. Verfasst von Simon M Mueller und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University Hospital Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: Prurigo, Dermatologic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Management of chronic prurigo (CPG), including prurigo nodularis (PN), is challenging due to its chronic, often treatment‐refractory course, high disease burden, and increasing complexity of therapies. International guidelines are partly outdated and may not fully reflect country‐specific considerations. Our aim was to develop practice recommendations for the diagnosis and treatment of CPG. Twelve hospital‐ and practice‐based experts formulated recommendations following a standardized literature review and structured expert consensus process, with recommendations voted on until ≥ 75% agreement was reached. Recommendation levels were guided by the GRADE methodology but adapted to allow practical, differentiated guidance, including the additional “Can be considered” category. Recommendations address history taking, laboratory testing, biopsy, questionnaires, general measures, pharmacological and non‐pharmacological therapies. “We recommend” applies to topical corticosteroids, narrow‐band ultraviolet B (NB‐UVB), dupilumab, and nemolizumab; “We suggest” to topical calcineurin inhibitors, zinc oxide dressings, cryotherapy, intralesional corticosteroids, gabapentinoids, antidepressants, methotrexate, ciclosporin, μ‐opioid receptor antagonists, Janus kinase inhibitors, and cognitive behavioral techniques; and “Can be considered” to capsaicin, ultraviolet A1 (UVA1), psoralen plus ultraviolet A (PUVA), and sedating antihistamines for sleep. No recommendation could be made for azathioprine, non‐sedating antihistamines, κ‐opioid receptor agonists, retinoids, neurokinin‐1 receptor antagonists, thalidomide, or lenalidomide. These recommendations provide comprehensive, up‐to‐date guidance for CPG, supporting clinicians in Switzerland and internationally. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, University Hospital Basel, Basel, Switzerland.
- Department of Dermatology, Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland.
- Division of Dermatology and Venereology, Geneva University Hospitals, Geneva, Switzerland.
- Division of Dermatology and Allergology, HOCH Health Ostschweiz, St Gallen, Switzerland.
- Private Practice Basel, Basel, Switzerland.
- Dermatology & Skin Care Clinic, Buochs, Switzerland.
ORCID-Profile: Simon M Mueller, Helmut Beltraminelli, Wolf-Henning Boehncke, Antonio Cozzio, Antonios G A Kolios, Claudia Lang, Eva Loos, Christoph Schlapbach, Curdin Conrad
Zitieren
APA
Mueller, S. M., Beltraminelli, H., Boehncke, W. H., Böhm, M., Cozzio, A., Häusermann, P., Jalili, A., Kolios, A. G. A., Lang, C., Loos, E., Schlapbach, C., & Conrad, C. (2026). Swiss Practice Recommendations for Chronic Prurigo Including Prurigo Nodularis. International Journal of Dermatology, 65(12), 2497-2508. https://doi.org/10.1111/ijd.70533
Vancouver
Mueller SM, Beltraminelli H, Boehncke WH, Böhm M, Cozzio A, Häusermann P, et al. Swiss Practice Recommendations for Chronic Prurigo Including Prurigo Nodularis. International Journal of Dermatology. 2026;65(12):2497-2508. doi:10.1111/ijd.70533
BibTeX
@article{Mueller2026,
author = {Mueller, Simon M and Beltraminelli, Helmut and Boehncke, Wolf-Henning and Böhm, Maximilian and Cozzio, Antonio and Häusermann, Peter and Jalili, Ahmad and Kolios, Antonios G A and Lang, Claudia and Loos, Eva and Schlapbach, Christoph and Conrad, Curdin},
title = {Swiss Practice Recommendations for Chronic Prurigo Including Prurigo Nodularis},
journal = {International Journal of Dermatology},
year = {2026},
volume = {65},
number = {12},
pages = {2497--2508},
doi = {10.1111/ijd.70533}
}
EUVIMED